These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26513296)

  • 21. hsa-miR-631 resensitizes bortezomib-resistant multiple myeloma cell lines by inhibiting UbcH10.
    Xi H; Li L; Du J; An R; Fan R; Lu J; Wu YX; Wu SX; Hou J; Zhao LM
    Oncol Rep; 2017 Feb; 37(2):961-968. PubMed ID: 28000886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bortezomib resistance in a myeloma cell line is associated to PSMβ5 overexpression and polyploidy.
    Balsas P; Galán-Malo P; Marzo I; Naval J
    Leuk Res; 2012 Feb; 36(2):212-8. PubMed ID: 21978467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reovirus: Rationale and clinical trial update.
    Lal R; Harris D; Postel-Vinay S; de Bono J
    Curr Opin Mol Ther; 2009 Oct; 11(5):532-9. PubMed ID: 19806501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NEDD8 Inhibition Overcomes CKS1B-Induced Drug Resistance by Upregulation of p21 in Multiple Myeloma.
    Huang J; Zhou Y; Thomas GS; Gu Z; Yang Y; Xu H; Tricot G; Zhan F
    Clin Cancer Res; 2015 Dec; 21(24):5532-42. PubMed ID: 26156395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abrogation of junctional adhesion molecule-A expression induces cell apoptosis and reduces breast cancer progression.
    Murakami M; Giampietro C; Giannotta M; Corada M; Torselli I; Orsenigo F; Cocito A; d'Ario G; Mazzarol G; Confalonieri S; Di Fiore PP; Dejana E
    PLoS One; 2011; 6(6):e21242. PubMed ID: 21695058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The combination of intravenous Reolysin and gemcitabine induces reovirus replication and endoplasmic reticular stress in a patient with KRAS-activated pancreatic cancer.
    Mahalingam D; Patel S; Nuovo G; Gill G; Selvaggi G; Coffey M; Nawrocki ST
    BMC Cancer; 2015 Jul; 15():513. PubMed ID: 26156229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment.
    Bolomsky A; Schlangen K; Schreiner W; Zojer N; Ludwig H
    J Hematol Oncol; 2016 Mar; 9():17. PubMed ID: 26935956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression Profiles of the Individual Genes Corresponding to the Genes Generated by Cytotoxicity Experiments with Bortezomib in Multiple Myeloma.
    Ghasemi M; Alpsoy S; Türk S; Malkan ÜY; Atakan Ş; Haznedaroğlu İC; Güneş G; Gündüz M; Yılmaz B; Etgül S; Aydın S; Aslan T; Sayınalp N; Aksu S; Demiroğlu H; Özcebe OI; Büyükaşık Y; Göker H
    Turk J Haematol; 2016 Dec; 33(4):286-292. PubMed ID: 27095044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma.
    Gomez-Bougie P; Wuillème-Toumi S; Ménoret E; Trichet V; Robillard N; Philippe M; Bataille R; Amiot M
    Cancer Res; 2007 Jun; 67(11):5418-24. PubMed ID: 17545623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Junctional adhesion molecule-A promotes proliferation and inhibits apoptosis of gastric cancer.
    Ikeo K; Oshima T; Shan J; Matsui H; Tomita T; Fukui H; Watari J; Miwa H
    Hepatogastroenterology; 2015; 62(138):540-5. PubMed ID: 25916097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-451 regulates stemness of side population cells via PI3K/Akt/mTOR signaling pathway in multiple myeloma.
    Du J; Liu S; He J; Liu X; Qu Y; Yan W; Fan J; Li R; Xi H; Fu W; Zhang C; Yang J; Hou J
    Oncotarget; 2015 Jun; 6(17):14993-5007. PubMed ID: 25915427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reovirus-based therapy for cancer.
    Kelly K; Nawrocki S; Mita A; Coffey M; Giles FJ; Mita M
    Expert Opin Biol Ther; 2009 Jul; 9(7):817-30. PubMed ID: 19527106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncolytic reovirus combined with trastuzumab enhances antitumor efficacy through TRAIL signaling in human HER2-positive gastric cancer cells.
    Hamano S; Mori Y; Aoyama M; Kataoka H; Tanaka M; Ebi M; Kubota E; Mizoshita T; Tanida S; Johnston RN; Asai K; Joh T
    Cancer Lett; 2015 Jan; 356(2 Pt B):846-54. PubMed ID: 25444894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EZH2 Modulates the DNA Methylome and Controls T Cell Adhesion Through Junctional Adhesion Molecule A in Lupus Patients.
    Tsou PS; Coit P; Kilian NC; Sawalha AH
    Arthritis Rheumatol; 2018 Jan; 70(1):98-108. PubMed ID: 28973837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bortezomib overcomes cell-adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma.
    Noborio-Hatano K; Kikuchi J; Takatoku M; Shimizu R; Wada T; Ueda M; Nobuyoshi M; Oh I; Sato K; Suzuki T; Ozaki K; Mori M; Nagai T; Muroi K; Kano Y; Furukawa Y; Ozawa K
    Oncogene; 2009 Jan; 28(2):231-42. PubMed ID: 18850009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ras transformation mediates reovirus oncolysis by enhancing virus uncoating, particle infectivity, and apoptosis-dependent release.
    Marcato P; Shmulevitz M; Pan D; Stoltz D; Lee PW
    Mol Ther; 2007 Aug; 15(8):1522-30. PubMed ID: 17457318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of oncolytic reovirus in canine lymphoma cell lines.
    Hwang CC; Umeki S; Igase M; Coffey M; Noguchi S; Okuda M; Mizuno T
    Vet Comp Oncol; 2016 Aug; 14 Suppl 1():61-73. PubMed ID: 25319493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atherogenic mononuclear cell recruitment is facilitated by oxidized lipoprotein-induced endothelial junctional adhesion molecule-A redistribution.
    Schmitt MM; Fraemohs L; Hackeng TM; Weber C; Koenen RR
    Atherosclerosis; 2014 Jun; 234(2):254-64. PubMed ID: 24704627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of GSK-3beta enhances reovirus-induced apoptosis in colon cancer cells.
    Min HJ; Koh SS; Cho IR; Srisuttee R; Park EH; Jhun BH; Kim YG; Oh S; Kwak JE; Johnston RN; Chung YH
    Int J Oncol; 2009 Sep; 35(3):617-24. PubMed ID: 19639182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of immunohistochemistry to determine oncolytic reovirus distribution and replication in-human tumors.
    Kapadia R; Coffey MC
    Methods; 2010 Dec; 52(4):301-6. PubMed ID: 20801221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.